Machine Learning

AI differentiates COVID-19 from other pneumonia


Excerpt from the article: “Researchers from China have developed an artificial intelligence (AI) algorithm that accurately detects COVID-19 and differentiates it from community-acquired pneumonia and other lung diseases. They shared their results in an article published online March 19 in Radiology.” Click the button below to read the entire article! Continue To The Article

Read More

Build Your Neurotech Venture with The ONtrepreneurs (Ontario Neurotech Entrepreneurs) Program!


The ONtrepreneurs (Ontario Neurotech Entrepreneurs) Program is Canada’s single largest award that catalyzes early stage entrepreneurs to commercialize brain-related technologies by accessing funding and support to launch or grow their neurotechnology ventures. Application for the 2020 ONtrepreneurs Competition is NOW OPEN! Click the button below to read his entire Article! Continue To The Site To…

Read More

Meet with Christopher Kata in Milwaukee March 17th to 18th!


Meet with Christopher Kata, Director of Sales & Marketing March 17th to 18th, in Milwaukee, Wisconsin. Christopher is in town on business and has availability for additional meetings. Arrange to meet in person and learn how TrialStat is leading the way with their innovative, interoperable Electronic Data Capture (Data Management) platform. Learn how you can…

Read More

Meet with Christopher Kata in San Diego March 3rd to 4th!


Meet with Christopher Kata, Director of Sales and Marketing March 3rd to 4th, San Diego, California. Christopher is in town for client meetings and has availability for additional meetings. Christopher Kata, Director of Sales & Marketing905 [email protected] Arrange to meet in person and learn how TrialStat is leading way in innovative, interoperable Electronic Data Capture…

Read More

Thank you again to all the attendees and organizers at SCOPE Summit for making the conference a huge success!


We met incredible researchers, partners, and solution providers at the event, and thanks to our on the ground team Christopher Kata, Heather Williams, and Chris Hamelin, we were able to engage with them using our recently released eClinical Technology interoperability diagram that maps out TrialStat’s innovative advances in Trial Management Technology, Vendor Neutral Imaging Archive,…

Read More

Data and Digital takeaways from J.P. Morgan 2020


Bruno Villetelle, Head of Data and Digital, Novartis Global Drug Development, wrote a very succinct summary of the core topics covered at J.P. Morgan 2020. We’re excited to see the continued momentum behind these digital trends and how we’re enabling Sponsors to take advantage of Real World Data, Machine Learning and so much more through…

Read More

World first as drug developed using AI enters clinical trials


This may just be the first drug to be generated using artificial intelligence (AI) which has now entered clinical trials in Japan. “The project has been particularly heralded for the speed it took to complete – taking just 12 months when compared to the typical five years it takes drug companies to complete the research…

Read More

Microsoft takes the wraps off $40 million, five-year ‘AI for Health’ initiative


Microsoft has recently announced a $40 Million investment in AI for Health Initiatives. “Through its AI for Good projects, Microsoft is applying lessons from software to artificial intelligence technologies that are under development. In the case of health, Microsoft officials said their mission is to use insights derived from AI technologies and techniques to search…

Read More

Google Shows AI Can Spot Breast Cancer Better Than Doctors


According to new research from Google Health, AI can more accurately detect breast cancer than physicians. “The technology’s reading of mammograms reduced both false positives, where healthy patients are mistakenly diagnosed with the disease, and false negatives, where the cancer is missed, the Alphabet Inc. unit said in a blog post on Wednesday. The system reduced false positives by…

Read More

AI in Drug Discovery and Development: Emerging Technologies and Applications


This year at DIA one of the overriding themes was with the value and benefit of Machine Learning and Artificial Intelligence. One of these sessions was of particular interest and a summary has since been published by DIA. “Assembling experts from the application and research side of drug discovery, the session AI in Drug Discovery…

Read More